Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trialThe Lancet (British edition), 2015-11, Vol.386 (10008), p.2078-2088 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Nov 21, 2015 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(15)00239-1 ;PMID: 26386540 ;CODEN: LANCAOFull text available |
2 |
Material Type: Article
|
![]() |
Human papillomavirus as a driver of head and neck cancersBritish journal of cancer, 2020-02, Vol.122 (3), p.306-314 [Peer Reviewed Journal]2019© The Author(s), under exclusive licence to Cancer Research UK 2019 ;The Author(s), under exclusive licence to Cancer Research UK 2019 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-019-0602-7 ;PMID: 31708575Full text available |
3 |
Material Type: Article
|
![]() |
Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysisBritish journal of cancer, 2019-11, Vol.121 (11), p.954-965 [Peer Reviewed Journal]2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-019-0593-4 ;PMID: 31616037Full text available |
4 |
Material Type: Article
|
![]() |
The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell lineNature (London), 2013-08, Vol.500 (7461), p.207-211 [Peer Reviewed Journal]COPYRIGHT 2013 Nature Publishing Group ;COPYRIGHT 2013 Nature Publishing Group ;Copyright Nature Publishing Group Aug 8, 2013 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature12064 ;PMID: 23925245 ;CODEN: NATUASFull text available |
5 |
Material Type: Article
|
![]() |
A Phase II, Prospective, Randomized, Multicenter, Open-Label Study of GX-188E, an HPV DNA Vaccine, in Patients with Cervical Intraepithelial Neoplasia 3Clinical cancer research, 2020-04, Vol.26 (7), p.1616-1623 [Peer Reviewed Journal]2019 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-19-1513 ;PMID: 31727676Full text available |
6 |
Material Type: Article
|
![]() |
HPV and DNA Methylation Testing in Urine for Cervical Intraepithelial Neoplasia and Cervical Cancer DetectionClinical cancer research, 2022-05, Vol.28 (10), p.2061-2068 [Peer Reviewed Journal]2022 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-21-3710 ;PMID: 35266975Full text available |
7 |
Material Type: Article
|
![]() |
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA studyThe lancet oncology, 2011-09, Vol.12 (9), p.880-890 [Peer Reviewed Journal]Elsevier Ltd ;2011 Elsevier Ltd ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Sep 2011 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(11)70188-7 ;PMID: 21865084 ;CODEN: LANCAOFull text available |
8 |
Material Type: Article
|
![]() |
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trialThe lancet oncology, 2012, Vol.13 (1), p.89-99 [Peer Reviewed Journal]Elsevier Ltd ;2012 Elsevier Ltd ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 2012 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(11)70286-8 ;PMID: 22075171 ;CODEN: LANCAOFull text available |
9 |
Material Type: Article
|
![]() |
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE studyThe Lancet (British edition), 2014-12, Vol.384 (9961), p.2213-2227 [Peer Reviewed Journal]Elsevier Ltd ;2014 Elsevier Ltd ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 27, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)60920-X ;PMID: 25189358 ;CODEN: LANCAOFull text available |
10 |
Material Type: Article
|
![]() |
Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screeningBritish journal of cancer, 2020-05, Vol.122 (11), p.1715-1723 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-0790-1 ;PMID: 32242098Full text available |
11 |
Material Type: Article
|
![]() |
Clinical Performance of the BD Onclarity Extended Genotyping Assay for the Management of Women Positive for Human Papillomavirus in Cervical Cancer ScreeningCancer epidemiology, biomarkers & prevention, 2022-04, Vol.31 (4), p.851-857 [Peer Reviewed Journal]2022 American Association for Cancer Research. ;ISSN: 1055-9965 ;EISSN: 1538-7755 ;DOI: 10.1158/1055-9965.EPI-21-1082 ;PMID: 35131879Full text available |
12 |
Material Type: Article
|
![]() |
Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV typesBritish journal of cancer, 2014-05, Vol.110 (11), p.2804-2811 [Peer Reviewed Journal]2015 INIST-CNRS ;Copyright Nature Publishing Group May 27, 2014 ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2014 Cancer Research UK 2014 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2014.198 ;PMID: 24736582 ;CODEN: BJCAAIFull text available |
13 |
Material Type: Article
|
![]() |
Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT TrialJNCI : Journal of the National Cancer Institute, 2018-02, Vol.110 (2), p.205-212 [Peer Reviewed Journal]Published by Oxford University Press 2017. This work is written by US Government employees and is in the public domain in the US. ;Published by Oxford University Press 2017. This work is written by US Government employees and is in the public domain in the US. 2017 ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djx158 ;PMID: 28954299Full text available |
14 |
Material Type: Article
|
![]() |
The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilotBritish journal of cancer, 2022-07, Vol.127 (2), p.278-287 [Peer Reviewed Journal]2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-022-01791-w ;PMID: 35347326Full text available |
15 |
Material Type: Article
|
![]() |
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trialThe lancet oncology, 2012, Vol.13 (1), p.100-110 [Peer Reviewed Journal]Elsevier Ltd ;2012 Elsevier Ltd ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 2012 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(11)70287-X ;PMID: 22075170 ;CODEN: LANCAOFull text available |
16 |
Material Type: Article
|
![]() |
p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive WomenJNCI : Journal of the National Cancer Institute, 2021-03, Vol.113 (3), p.292-300 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com 2020 ;The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djaa105 ;PMID: 32745170Full text available |
17 |
Material Type: Article
|
![]() |
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical LesionsThe New England journal of medicine, 2007-05, Vol.356 (19), p.1915-1927 [Peer Reviewed Journal]Copyright © 2007 Massachusetts Medical Society. All rights reserved. ;2007 INIST-CNRS ;Copyright 2007 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa061741 ;PMID: 17494925 ;CODEN: NEJMAGFull text available |
18 |
Material Type: Article
|
![]() |
Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer CellsJournal of virology, 2019-04, Vol.93 (8) [Peer Reviewed Journal]Copyright © 2019 American Society for Microbiology. ;Copyright © 2019 American Society for Microbiology. 2019 American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/JVI.01808-18 ;PMID: 30728257Full text available |
19 |
Material Type: Article
|
![]() |
Self-coalescing flows in microfluidics for pulse-shaped delivery of reagentsNature (London), 2019-10, Vol.574 (7777), p.228-232 [Peer Reviewed Journal]COPYRIGHT 2019 Nature Publishing Group ;COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Oct 10, 2019 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-019-1635-z ;PMID: 31597972Full text available |
20 |
Material Type: Article
|
![]() |
The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral PromotersJournal of virology, 2015-08, Vol.89 (15), p.7506-7520 [Peer Reviewed Journal]Copyright © 2015, American Society for Microbiology. All Rights Reserved. ;Copyright © 2015, American Society for Microbiology. All Rights Reserved. 2015 American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/JVI.00013-15 ;PMID: 25972554Full text available |